BLS Pharmaceuticals reports revenue spike in first quarter by Steve Jones October 15, 2026October 15, 2026 BLS Pharmaceuticals delivered revenue of almost $27 million in the first quarter of FY27, 90% higher […]
Cannabis executive salaries: who earned what in FY26 by Adam Sheldon October 15, 2026October 16, 2026
Digital marketing agency invests $18m to become major BLS shareholder as Kirkman Trading withdraws by Steve Jones October 10, 2026October 14, 2026
BLS sees potential FY27 ‘upside’ as UK facility nears launch by Adam Sheldon September 8, 2026September 9, 2026
BLS triples profit, tips revenue to grow up to 55% in FY27 by Adam Sheldon August 31, 2026August 31, 2026
‘This is just the beginning’: BLS CEO on German expansion and vision for firm by Adam Sheldon August 6, 2026August 6, 2026
BLS hits top end of guidance after strong final quarter of FY26 by Steve Jones July 27, 2026July 28, 2026
News in brief: Legalise Cannabis Victoria seeks $10,000; Bioxyne confirms BLS rebrand by Adam Sheldon June 29, 2026July 2, 2026
